Announcements Trials
Browse Landscape

Phase

Phase 3 22Phase 2 17Phase 1 6Phase 4 5

Status

Terminated 3Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 7INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 4Breast 1

Conditions

Prostatic Neoplasms 3Neoplasms 1Breast Neoplasms 1Advanced Prostate Cancer 1

Interventions

Zoledronic Acid 23Bevacizumab 13nilotinib 12Docetaxel 12Paclitaxel 11Everolimus 11Letrozole 10Imatinib Mesylate 10Capecitabine 10Erlotinib Hydrochloride 9Drug Therapy 9Carboplatin 9pegfilgrastim 8enzalutamide 8Trastuzumab 7Oxycodone 7Nivolumab 7Imiquimod 7Gemcitabine 7Epoetin Alfa 7icotinib 6Rituximab 6Prednisone 6Pemetrexed 6Oxaliplatin 6Leuprolide 6Fulvestrant 6Diclofenac 6Dexamethasone 6Cisplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × INDUSTRY × Goserelin × Clear all
NCT05161195 2026-04-02

Roll-over Study to Allow Continued Access to Ribociclib

Novartis

Phase 4 Active not recruiting
134 enrolled
Breast

Breast Neoplasms

NCT01673984 2025-05-23

GREAT

Ipsen

Phase 4 Terminated
27 enrolled 13 charts
Genitourinary

Prostatic Neoplasms

NCT03971110 2022-12-16

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.

AstraZeneca

Phase 4 Terminated
9 enrolled
Genitourinary

Advanced Prostate Cancer

NCT02749825 2016-04-25

Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer

Pharmatech

Phase 4 Terminated
41 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

NCT00255268 2007-08-28

CMAB vs IMAB in Metastatic Prostate Cancer

AstraZeneca

Phase 4 Withdrawn
15 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡